Max achieves big, despite his ataxia
Read about Max’s journey to his ataxia diagnosis, and his love for media.
Max achieves big, despite his ataxia Read More »
Read about Max’s journey to his ataxia diagnosis, and his love for media.
Max achieves big, despite his ataxia Read More »
Read a summary of the impact of Ataxia UK-funded research in the Research Impact Report 2020
Research Impact Report 2020 Read More »
Ataxia UK’s Co-Chair Richard Brown tells us about his life in lockdown.
Lockdown life with ataxia: part one Read More »
Dr Marta Olejniczak and her colleagues have used a genetic tool to silence the expression of mutated genes containing expanded CAG repeats in patient-derived cell lines of various ataxias.
Genetic approach to treat many spinocerebellar ataxias Read More »
This strange new reality feels like a temporary apocalypse, an unwelcome interruption to our daily norms
Ataxia VS Covid-19 Read More »
The measure is always in dusting yourself off, and to keep trying until all the incredible hard work sticks
A Time for Reflection Read More »
Ami Hook-Ireland shares her story of the challenges she faced living with ataxia and how ongoing support made a positive difference in her life.
The importance of support: before and after receiving a diagnosis Read More »
Staff are working from home due to Covid-19, find out how you can contact the office.
Self-isolation can be lonely and boring. That’s why we have created a series of online activities to bring the ataxia community together!
Now that’s what Ataxia UK calls lockdown Read More »
David has late-onset spinocerebellar ataxia type 6 and has written a blog about different forms of mobility assistance in hope that it will help anyone considering to purchase one.
“Everyday is Different Depending on my Stability” Read More »
Research shows exenatide increases frataxin in cell models and platelets in people with FA.
Exenatide in FA research Read More »
Here is Mari Durward-Akhurst to tell the story of her incredible achievement, and the roots of her riding.
“Winning the European Team Silver Medal was indescribable, a dream come true” Read More »
The latest information on becoming an Ataxia Ambassador!
Ataxia Ambassadors Read More »
We interviewed members of the 16-30’s group about topics such as relationships, living independently and exercise with ataxia.
The Mark Dower Trust offers a grant to promote independence for people aged between 16 and 30 with ataxia. Find out more here.
The Mark Dower Trust Read More »
Due to circumstances with the spread of coronavirus, Ataxia UK has decided to postpone the Scottish Conference which was due to happen in June 2020.
Ataxia UK’s Scottish Conference postponed Read More »
Being part of the 16-30’s group means you can join in with various events going on. Click here to find out what’s on offer!
How Covid-19 can affect someone with ataxia and ways to keep yourself safe during this pandemic.
Implications of coronavirus (covid-19) for people with ataxia Read More »
Exicure have announced Friedreich’s ataxia (FA) as the therapeutic indication for the company’s first neurology development programme for their gene therapy technology.
Exicure to launch gene therapy programme in Friedreich’s ataxia Read More »
A research group in Italy will soon be launching a clinical trial in an effort to repurpose anti-viral drug Etravirine for use in FA.
Ataxia UK I’m not drunk awareness ID cards.
Ataxia UK “I’m not drunk” ID card Read More »
Triplet Therapeutics are developing a new treatment that aims to address the underlying cause of the genetic dysfunction responsible for repeat expansion disorders including various SCAs.
Leading gene therapy uniQure have published data on their gene therapy candidate AMT-150.
uniQure publishes data from spinocerebellar ataxia type 3 gene therapy study Read More »
The incredibly motivated man David Arnold is wearing shorts every day during 2019. Read his story here.
365 days of shorts Read More »
Chondrial Therapeutics recently announced that the first person has been treated in a Phase 1 clinical trial to assess the safety and tolerability of CTI-1601.
Chondrial Therapeutics Announces Dosing of First Patients in Phase 1 FA trial Read More »
A project targeting the genetic cause of DRPLA, a rare form of ataxia, has received further funding from Ataxia UK.
Targeting the genetic cause of DRPLA Read More »
An Ataxia UK funded project using an innovative gene editing approach has identified 23 potential drug targets.
Friedreich’s ataxia research project identifies new drug targets Read More »
Find out what this year’s money will be going towards…
The Big Give – you did it! Read More »
Anita Gracey has Friedreich’s ataxia and writes poems about how her condition affects her life.
A Social Worker, a Home-Help and a GP walk into a Service User’s life Read More »
Episodic ataxia type 1 results, International Ataxia Awareness Day, Music therapy and finding the right aid for you.
Ataxia Magazine 207 Read More »